Indian drugmaker Aurobindo Pharma reported a lower third-quarter profit on Thursday, as a spike in expenses more than offset strong demand for its generic drugs.

A research by the George Institute for Global Health, with collaborators from Strathmore Business School in Kenya and the London School of Hygiene and Tropical Medicine, has called for a robust ...

Indian pharmaceutical companies lag behind global peers in ESG practices, facing regulatory, awareness, and resource ...

India's apex drug advisory body has been inactive since its term ended in October. This was brought to the health ministry's ...

India on Wednesday reaffirmed its commitment to global pharmaceutical standardisation and regulatory convergence.

By Kashish Tandon and Rishika Sadam HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India's largest drugmaker by revenue, ...

India's J B Chemicals & Pharmaceuticals reported a bigger third-quarter profit on Tuesday, helped by sustained domestic demand for its drugs for chronic and acute conditions.

Shares of Abbott India surged 5.60% higher at ₹27,605.45 on the BSE on Tuesday. The pharma stock reacted positively to the ...

India's trade surplus with the US and its reliance on American trade policy for US dollar earnings make it a key player.